Treatment of culture-negative skull base osteomyelitis

Otology and Neurotology

Volumn 27, Issue 2, 2006, Pages 250-255

  Djalilian, Hamid R ^a   Shamloo, Bahman ^b   Thakkar, Kunal H ^b   Najme Rahim, Mojdeh ^b  

^a Los Angeles County General Hospital   (United States)

^b NONE

Author keywords

Antibiotics; Malignant otitis externa; Necrotizing otitis externa; Skull base osteomyelitis; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; EAR DROPS; GALLIUM; HYDROCORTISONE; NEOMYCIN; POLYMYXIN; QUINOLONE DERIVATIVE; TECHNETIUM;

ADULT; AGED; ANTIBIOTIC THERAPY; CLINICAL ARTICLE; CULTURE MEDIUM; DIABETES MELLITUS; EXTERNAL AUDITORY CANAL; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; MALE; OSTEOMYELITIS; OTALGIA; OUTCOME ASSESSMENT; PENICILLIN ALLERGY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SKULL BASE OSTEOMYELITIS; SKULL SCINTISCANNING; TEMPORAL BONE; TERTIARY HEALTH CARE;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES; SKULL BASE; TECHNETIUM; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33645068176     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/01.mao.0000181185.26410.80     Document Type: Review

References (14)

1. Meltzer PE, Kelemen G. Pyocyaneus osteomyelitis of the temporal bone, mandible, and zygoma. Laryngoscope 1959;169:1300-16.
2. Slattery WH III, Brackmann DE. Skull base osteomyelitis: malignant external otitis. Otolaryngol Clin North Am 1996;29:795-806.
3. Soldati D, Mudry A, Monnier P. Necrotizing otitis externa caused by Staphylococcus epidermidis. Eur Arch Otorhinolaryngol 1999;256:439-41.
4. Babiatzki A, Sade J. Malignant external otitis. J Laryngol Otol 1987;101:205-10.
5. Menachof MR, Jackler RK. Otogenic skull base osteomyelitis caused by invasive fungal infection. Otolaryngol Head Neck Surg 1990;102:285-9.
6. Cunningham M, Yu VL, Turner J, Curtin H. Necrotizing otitis externa due to Aspergillus in an immunocompetent patient. Arch Otolaryngol Head Neck Surg 1988;114:554-6.
7. Levenson MJ, Parisier SC, Dolitsky J, Bindra G. Ciprofloxacin: drug of choice in the treatment of malignant external otitis (MEO). Laryngoscope 1991;101:821-4.
8. Shah A, Lettieri J, Kaiser L, Echols R, Heller AH. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg po twice daily. J Antimicrob Chemother 1994;33:795-801.
9. Karlowsky JA, Draghi DC, Jones ME, et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother 2003;47:1681-8.
10. Jang CH, Park SY. Emergence of ciprofloxacin-resistant pseudomonas in chronic suppurative otitis media. Clin Otolaryngol 2004;29:321-3.
11. Berenholz L, Katzenell U, Harell M. Evolving resistant pseudomonas to ciprofloxacin in malignant otitis externa. Laryngoscope 2002;112:1619-22.
12. Rubin J, Stoehr G, Yu VL, Muder RR, Matador A, Kamerer DB. Efficacy of oral ciprofloxacin plus rifampin for treatment of malignant external otitis. Arch Otolaryngol Head Neck Surg 1989;115:1063-9.
13. Davis JC, Gates GA, Lerner C, Davis MG Jr, Mader JT, Dinesman A. Adjuvant hyperbaric oxygen in malignant external otitis. Arch Otolaryngol Head Neck Surg 1992;118:89-93.
14. Grobman LR, Ganz W, Casiano R, Goldberg S. Atypical osteomyelitis of the skull base. Laryngoscope 1989;99:671-76.